Right-to-Try Bills Push the Needle on Risk

Tony Hagen @oncobiz
Published: Sunday, Dec 24, 2017
Diana Zuckerman, PhD

Diana Zuckerman, PhD
Congressional “right-to-try” legislation could make investigational drugs available to desperately ill patients sooner in the trials process, but there are substantial risks, said a panel of experts at the Patient-Centered Oncology Conference, held November 16-17 in Philadelphia, Pennsylvania.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication